Olympus Corp. (OLYMY)
9.52
-0.33
(-3.35%)
USD |
OTCM |
Feb 20, 16:00
Olympus EPS Diluted (Quarterly) : 0.0833 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nxera Pharma Co., Ltd. | -0.5548 |
| PeptiDream Inc. | -0.0267 |
| Stemcell Holdings, Inc. | -- |
| Healios KK | 0.1226 |
| AnGes, Inc. | -0.0052 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 91.97M |
| Revenue (Quarterly) | 1.694B |
| Total Expenses (Quarterly) | 1.602B |
| Enterprise Value | 11.11B |
| Gross Profit Margin (Quarterly) | 63.17% |
| Profit Margin (Quarterly) | 5.43% |
| Earnings Yield | 5.26% |
| Operating Earnings Yield | 9.54% |
| Normalized Earnings Yield | 5.407 |